The 5-year overall survival (OS) curve of the ovarian cancer patients with respect to RFP expression showed a trend toward poor prognosis for the patients with positive RFP immunoreactivity, although it was not statistically significant ( P = 0.1266, Fig. 1 B).
← all excerpts
Expression of RET finger protein predicts chemoresistance in epithelial ovarian cancer.
1
—
—